Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.49 |
| ▸ | MYC | P01106 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.48 |
| ▸ | F7 | P08709 | 1/20 | 0.47 |
| ▸ | F3 | P13726 | 1/20 | 0.47 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3480768 | 0.98 | TP53 (0.61) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL3480767 | 0.96 | TP53 (0.59) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL15137264 | 0.83 | ALDH1A1 (0.48) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL1669829 | 0.83 | ALDH1A1 (0.47) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL395189 | 0.83 | SMN1; SMN2 (0.63) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL24821886 | 0.81 | ALDH1A1 (0.55) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL29494150 | 0.81 | F2R (0.48) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL3121226 | 0.81 | F2R (0.48) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL1000440 | 0.79 | ALDH1A1 (0.71) | TP53ALDH1A1CA1CA2TSHR | |
| SCHEMBL19514758 | 0.79 | ALDH1A1 (0.71) | TP53ALDH1A1CA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634196-A1 | PERACID PROMOTERS IN THE IRIDIUM-CATALYZED HYDROSILYLATION SYNTHESIS OF HALOALKYLORGANOSILANES | Momentive Performance Materials GmbH (DE) | 2025-10-22 | — | — | EP | claimed |
| CN-118790960-B | Hollow nano tubular carbon nitride structure modification and photocatalytic decomposition hydrogen production method | 中国电建集团西北勘测设计研究院有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118790960-A | Hollow nano tubular carbon nitride structure modification and photocatalytic decomposition hydrogen production method | 中国电建集团西北勘测设计研究院有限公司 | 2024-10-18 | — | — | CN | claimed |
| WO-2024126692-A1 | PERACID PROMOTERS IN THE IRIDIUM-CATALYZED HYDROSILYLATION SYNTHESIS OF HALOALKYLORGANOSILANES | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2024-06-20 | — | — | WO | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-102351790-B | Method for synthesizing 7-bromo-6-chloro-4-quinazolinone | UNIV NANCHANG | 2013-12-04 | — | — | CN | claimed |
| CN-102351790-A | Method for synthesizing 7-bromo-6-chloro-4-quinazolinone | UNIV NANCHANG | 2012-02-15 | — | — | CN | claimed |
| CN-1651428-A | Preparation method of hydrobromic acid antifebrile dichroanone | SHANGHAI YINNUO BIOCHEMICAL SC (CN) | 2005-08-10 | — | — | CN | claimed |
| CN-122036551-A | Cypress alkyl ketone hydroxyoxaester derivative, preparation method and application thereof | 贵州省天然产物研究中心 | 2026-05-15 | — | — | CN | disclosed |
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-12605369-B2 | Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses | MERCK SHARP & DOHME LLC (US) | 2026-04-21 | — | — | US | disclosed |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | ORSOBIO, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-20260041672-A1 | Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators, Pharmaceutical Compositions, and Uses Thereof | UNIV EMORY (US) | 2026-02-12 | — | — | US | disclosed |
| US-12465595-B2 | Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof | EMORY UNIVERSITY (US) | 2025-11-11 | — | — | US | disclosed |
| US-5130318-A | Hypotensive agents and for treatment of congestive heart failure | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-07-14 | — | — | US | disclosed |
| CN-1055925-A | Pyridine derivate and preparation method thereof | ICI PLC (GB) | 1991-11-06 | — | — | CN | disclosed |
| EP-0453210-A2 | Pyridine derivatives | ZENECA LIMITED (GB) | 1991-10-23 | — | — | EP | disclosed |
| EP-0023569-B1 | DERIVATIVES OF CARBOXYLIC ACIDS, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1983-06-22 | — | — | EP | disclosed |
| EP-0023569-A1 | Derivatives of carboxylic acids, their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-3987186-A | ANTIALLERGENS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041672-A1 | Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators, Pharmaceutical Compositions, and Uses Thereof | CFTR, SCNN1B, CLCN2 | TP53 3750/4885ALDH1A1 2972/4885CA1 4673/4885 |
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | CBLB, CBLC, CBL | TP53 1943/4885ALDH1A1 3286/4885CA1 4437/4885 |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | NR3C2, NR5A1, SRD5A2 | TP53 4662/4885ALDH1A1 1507/4885CA1 3778/4885 |
| US-12465595-B2 | Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof | CFTR, CLCN2, SLC26A4 | TP53 2736/4885ALDH1A1 3631/4885CA1 4864/4885 |
| US-12605369-B2 | Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses | CXCR1, CCR1, CLIC1 | TP53 2817/4885ALDH1A1 2477/4885CA1 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.